News

The FDA may limit annual COVID-19 boosters to high-risk groups unless clinical trials prove benefits for healthy adults under ...
The US FDA may limit Covid-19 boosters to high-risk groups only, citing lack of efficacy in healthy individuals. Meanwhile, ...
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.
The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr.
The mRNA vaccines were developed using novel technology that was approved for the first time for public use during the COVID-19 pandemic.
The United States has identified multiple cases of a new COVID-19 variant, NB.1.8.1, which has been associated with the ...
Historically, almost everyone has been eligible for Covid vaccines; the C.D.C. recommended the most recent vaccine for all ...
Government advisers are meeting Thursday to decide if COVID-19 vaccines need updating to improve protection this fall and ...